date:Oct 29, 2012
uble blind placebo controlled design, the ethical protocol had to be written, pilots for biomarkers analysis performed etc. But thanks to the collaborative action of the dedicated partners we managed everything in time.
The clinical trial is organised by one of the FibeBiotics partners, Clinical Research Centre (CRC) in Kiel.
This pilot study should teach us what NPS compounds are interesting to include in follow-up studies, directly learn what number of persons should be included in a pivota